Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacific Northwest Retinal Center is a premier ophthalmology practice specializing in the diagnosis and treatment of vitreoretinal diseases, including macular degeneration, diabetic retinopathy, and retinal detachment. Based in Washington state, the center operates multiple clinical locations and a dedicated research department that participates in high-impact national and international clinical trials. The organization serves as a key clinical trial site for Phase 1 through Phase 3 studies, evaluating novel pharmacotherapies and gene therapies for blinding eye diseases. In 2021, the practice joined Retina Consultants of America (RCA), a leading network of retina specialists, to enhance its research capabilities and patient care resources. The center is recognized for integrating advanced diagnostic imaging and surgical techniques into its comprehensive clinical workflow.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pacific Northwest Retinal Center.